OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

News Network

September 5, 2018

September 5, 2018

September 10th 2018
August 29, 2018

August 29, 2018

September 1st 2018
August 22, 2018

August 22, 2018

August 27th 2018
August 8, 2018

August 8, 2018

August 13th 2018
August 1, 2018

August 1, 2018

August 6th 2018
July 18, 2018

July 18, 2018

July 20th 2018
July 11, 2018

July 11, 2018

July 13th 2018
July 4, 2018

July 4, 2018

July 7th 2018
2018 World Congress on GI Cancer Highlights

2018 World Congress on GI Cancer Highlights

June 30th 2018
June 27, 2018

June 27, 2018

June 30th 2018
PIVOT-02: NKTR-214 & Nivolumab

PIVOT-02: NKTR-214 & Nivolumab

June 28th 2018
First-Line therapy for Chronic Lymphocytic Leukemia

First-Line therapy for Chronic Lymphocytic Leukemia

June 28th 2018
June 20, 2018

June 20, 2018

June 23rd 2018
Advances in the Management of CRC

Advances in the Management of CRC

June 20th 2018
June 13, 2018

June 13, 2018

June 15th 2018
ASCO 2018 News

ASCO 2018 News

June 2nd 2018
Impact of CAR T-Cell Therapy for DLBCL

Impact of CAR T-Cell Therapy for DLBCL

May 25th 2018
Androgen Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

Androgen Deprivation Therapy in Prostate Cancer and Cardiovascular Risk

May 21st 2018
May 16, 2018

May 16, 2018

May 19th 2018
May 9, 2018

May 9, 2018

May 11th 2018
May 2, 2018

May 2, 2018

May 4th 2018
April 25, 2018

April 25, 2018

April 27th 2018
Targeting EGFR Exon 20 Mutation in NSCLC

Targeting EGFR Exon 20 Mutation in NSCLC

April 25th 2018
2018 AACR Annual Meeting Highlights

2018 AACR Annual Meeting Highlights

April 21st 2018
April 18, 2018

April 18, 2018

April 21st 2018
April 13, 2018

April 13, 2018

April 13th 2018
April 6, 2018

April 6, 2018

April 6th 2018
March 28, 2018

March 28, 2018

March 31st 2018
2018 SGO Annual Meeting Highlights

2018 SGO Annual Meeting Highlights

March 31st 2018
Emerging Treatment Options for BRCA-Mutated Breast Cancer

Emerging Treatment Options for BRCA-Mutated Breast Cancer

March 30th 2018
<1
...
456789101112
...
16>

Latest Conference Coverage

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma

Data for Luspatercept Highlight Evolving Treatment Landscape in Lower-Risk MDS

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact